Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, alpha-dimethyl-m-tyramine (H 77-77) in rats.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 4136728)

Published in Psychopharmacologia on January 01, 1974

Authors

J B Lassen

Articles by these authors

Potent and long-lasting potentiation of two 5-hydroxytryptophan- induced effects in mice by three selective 5-ht uptake inhibitors. Eur J Pharmacol (1978) 1.02

The effect of p-chloroamphetamine on motility in rats after inhibition of monoamine synthesis, storage, uptake and receptor interaction. Psychopharmacologia (1974) 1.00

Pharmacological and biochemical studies on 2-amino-4-phenylsulphonylbenzenesulphonamide (NSD 3004): a new sulphonamide with anticonvulsant and carbonic anhydrase inhibitory properties. Acta Pharmacol Toxicol (Copenh) (1971) 0.96

The inhibition of A and B forms of MAO in the production of a characteristic behabioural syndrome in rats after 1-tryptophan loading. Psychopharmacologia (1975) 0.93

Some pharmacological and biochemical properties of gamma-morpholino-butyrophenone (NSD 2023), a new monoamine oxidase inhibitor. Biochem Pharmacol (1968) 0.82

Pharmacological and toxicological studies on gamma-(4-methylpiperidino)-p-fluorobutyrophenone (FG 5111)--a new neuroleptic agent. Acta Pharmacol Toxicol (Copenh) (1965) 0.81

Neurochemical and pharmacological studies on a new 5HT-uptake inhibitor, FG4963, with potential antidepressant properties. Psychopharmacologia (1975) 0.80

The effect of amantadine and (+)-amphetamine on motility in rats after inhibition of monoamine synthesis and storage. Psychopharmacologia (1973) 0.79

Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics. Acta Pharmacol Toxicol (Copenh) (1979) 0.78

A water lick conflict paradigm using drug experienced rats. Psychopharmacology (Berl) (1981) 0.77

Comparative studies of a new 5HT-uptake inhibitor and some tricyclic thymoleptics. Eur J Pharmacol (1975) 0.77

Evidence for a noradrenergic mechanism in the grooming produced by (+)-amphetamine and 4, alpha-dimethyl-m-tyramine (H 77/77) in rats. Psychopharmacology (Berl) (1977) 0.75

Inhibition of apomorphine-induced hypermotility in rats by chlorpromazine, perphenazine, thioridazine and melperone. Acta Pharmacol Toxicol (Copenh) (1977) 0.75

Introduction to the development of paroxetine, a novel antidepressant. Acta Psychiatr Scand Suppl (1989) 0.75

Influence of the new 5-HT-uptake inhibitor paroxetine on hypermotility in rats produced by p-chloroamphetamine (PCA) and 4,alpha-dimethyl-7-tyramine (H 77/77). Psychopharmacology (Berl) (1978) 0.75

Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine. Psychopharmacology (Berl) (1980) 0.75

Inhibition and potentiation of apomorphine-induced hypermotility in rats by neuroleptics. Eur J Pharmacol (1976) 0.75

Elimination and distribution of menbutone (Genabil) in rats. Acta Pharmacol Toxicol (Copenh) (1969) 0.75

The distribution of 2-amino-4-phenylsulphonylbenzenesulphonamide (NSD 3004) in blood and its binding to blood components. Acta Pharmacol Toxicol (Copenh) (1971) 0.75

Potentiation of nialamide-induced hypermotility in mice by lithium and the 5-HT uptake inhibitors chlorimipramine and FG 4963. Neuropharmacology (1976) 0.75